Quinoline-2-carbohydrazide (2) obtained from quinaldic acid (1) was converted to the corresponding carbothioamide 3 and carboxamide 6 by treatment with benzyliso(thio)cyanate. The basic treatment of 3 and 6 yielded the corresponding 1,2,4-triazole derivatives 4 and 7. The synthesis of 5-(quinolin-2-yl)-1,3,4-oxadiazol-2-thiol (9) was performed from the reaction of 1 with CS2 in basic media. The Mannich reaction of compounds 4, 7, and 9 resulted in the formation of aminoalkylated derivatives 5a-c, 8, and 10a,b. The condensation of 1 with thiosemicarbazide, carbohydrazide, or thiocarbohydrazide gave the corresponding 1,2,4-triazole derivatives (11) (12) (13) . The treatment of 4-amino-5-(quinolin-2-yl)-4 H -1,2,4-triazole-3-thiol (13) with 4-chlorophenacyl bromide caused the formation of fused triazolothiadiazine 14. The condensation of 13 with 4-methoxybenzaldehyde generated the corresponding Schiff base 15.
Introduction
The steadily increasing bacterial resistance to first-line antibiotic agents has become a serious problem in antibacterial therapy and required continuing research into new classes of compounds possessing antimicrobial activities.
Infections caused by these resistant microorganisms fail to respond to treatment, resulting in prolonged illness and greater risk of death. The growing number of reports of antibiotic resistance worldwide has led to fears that some lethal human pathogens, such as Mycobacterium tuberculosis, will soon become untreatable.
1−6
These trends have emphasized the urgent need for new, more effective, and safe antibacterial agents and which in turn has opened up a new area of research for medicinal chemists. Besides the development of completely new agents possessing chemical characteristics that clearly differ from those of existing ones, there is another approach involving the combination of 2 or more biologically active heterocyclic systems in a single molecular scaffold.
7−12
Among the pharmacologically important heterocyclic compounds, quinoline and its derivatives have been shown to possess antimalarial, 13−15 antibiotic, 16, 17 anticancer, 18 anti-inflammatory, 19 antihypertensive, 20 tyrosine kinase PDGF-RTK inhibition, 21 and anti-HIV 22, 23 properties. Chloroquine, primaquine, mefloquine, and quinine constitute notable examples of the drugs containing the quinoline scaffold that are used for the treatment of malaria (Chart). 24, 25 Floroquinolones, which are closely related to the quinoline ring, constitute another important class of antimicrobial agents used for the treatment of the infectious caused by especially gram-negative bacteria. In addition, compounds incorporating a 1,2,4-triazole nucleus have been reported to possess a wide-range spectrum of chemotherapeutic activities including anti-inflammatory, 26 anticancer, 27−29 antidepressant, 30 antibacterial, 31−35 antifungal, 36 and anticonvulsant activities. 37 In recent years, some studies have been reported incorporating the synthesis and antimicrobial activities of compounds containing the quinoline and triazole nucleus in a single structure. 1,17,38−42 However, an extensive literature survey reveals that sufficient efforts have not been made to combine these heterocycles in the same molecular scaffold and to investigate their antimicrobial activity.
Multicomponent reactions have been considered a major part of synthetic organic chemistry with advantages ranging from lower reaction times and temperatures to higher yields. The amino alkylation of aromatic compounds by Mannich reaction has been reported to have considerable importance for designing efficient bioactive molecules. 43 As a part of our continuing study on the synthesis of biologically active compounds and on the basis of the fact that more efficacious antibacterial compounds can be designed by joining 2 or more biologically active heterocyclic systems together in a single molecular framework, 44 
4-Benzyl-5-(quinolin-2-yl)-4H -1,2,4-triazol-3-thiol (4).
A solution of carbothioamide 3 (10 mmol) in ethanol-water (1:1) was refluxed in the presence of 2 N NaOH for 3 h; then the resulting solution was cooled to room temperature and neutralized with 37% HCl. The precipitate formed was filtered off, washed with water, and recrystallized from dimethyl sulfoxide/water (1:1) General method for the synthesis of compounds 5a-c, 8, and 10a,b. Morpholine (for 5a and 8), methylpiperazine (for 5b), 2-(morpholin-4-yl)ethanamin (for 5c), phenyl piperazine (for 10a), or methyl piperidine-4-carboxylate (for 10b) (10 mmol) was added to a solution of compound 4 (for 5a-c), compound 7 (for 8), or compound 9 (for 10a,b) (10 mmol) in dry tetrahydrofuran and the mixture was stirred at room temperature in the presence of formaldehyde (40%, 1.5 mL) for 3 h. Then the resulting solution was kept overnight in cold conditions. The separated solid was collected by filtration and recrystallized from dimethyl sulfoxide-water (1:1) (for 5a and 5b) or ethanol (for 5c, 8, and 10a,b) to yield the target compounds. 
4-Benzyl-2-(morpholin-4-ylmethyl)-5-(quinolin-2-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one (8).
Yield 
3-[(4-Phenylpiperazin-1-yl)methyl]-5-(quinolin-2-yl)-1,3,4-oxadiazol-2(3H)-thione (10a

Methyl 1-{[5-(quinolin-2-yl)-2-thioxo-1,3,4-oxadiazol-3(2H)-yl]methyl}piperidin -4-carboxylate (10b
Synthesis of 5-(quinolin-2-yl)-1,3,4-oxadiazol-2-thiol (9).
Compound 2 (10 mmol) and CS 2 (10 mmol) were added to the solution of KOH (10 mmol) in 50 mL of H 2 O and 50 mL of ethanol and the reaction content was allowed to reflux for 6 h (the progress of the reaction was monitored by TLC). Then the ethanol was removed under reduced pressure and the resulting solution was acidified with concentrated HCl. The formed precipitate was filtered off, washed with water, and recrystallized from dimethyl sulfoxide-water Synthesis of compounds 11-13. In a round bottom flask attached to an air condenser, the mixture of compound 1 (10 mmol) and thiocarbohydrazide (for 11), carbohydrazide (for 12), or thiocarbonohydrazide (for 13) (10 mmol) was heated at melting temperature (about 156-160˚C) for 2 h. On cooling the reaction content to room temperature, a solid was obtained. This product was washed with hot NaHCO 3 solution and recrystallized from ethanol (for 11 and 12) or dimethyl sulfoxide (for 13) to give the desired product. -2-yl)-1,3,4-thiadiazol-2(H )-imine (11) 
5-(Quinolin
4-Amino-5-(quinolin-2-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one (12
4-Amino-5-(quinolin-2-yl)-4H -1,2,4-triazole-3-thiol (13
2-[6-(4-Chlorophenyl)-8H -[1,2,4]triazolo[4,3-d][1,3,4]thiadiazin-3-yl]quinoline (14).
The mixture of compound 13 (10 mmol) and 4-chlorophenacylbromide (10 mmol) in absolute ethanol was allowed to reflux in the presence of dried sodium acetate (20 mmol) for 12 h. Then the mixture was allowed to reach to room temperature and the solid formed was filtered off, washed with water several times, and recrystallized from ethyl acetate to afford the desired compound. 
4-{[(4-Methoxyphenyl)methylidene]amino}-5-(quinolin-2-yl)-4H-1,2,4-triazole-3-thiol (15).
In a round bottom flask attached to an air condenser, the mixture of compound 13 (10 mmol) and 4-methoxybenzaldehyde (10 mmol) was heated at 120˚C for 2 h. On cooling the reaction content to room temperature, a solid was obtained. This crude product was recrystallized from dimethyl sulfoxide to give the desired product. were flood-inoculated onto the surface of the MH agar and Sabouraud Dextrose Agar (SDA) (Difco, Detriot, MI, USA) and then dried. For C. albicans and C. tropicalis, SDA was used. Five millimeter diameter wells were cut from the agar using a sterile cork-borer, and 50 mL of the extract substances was delivered into the wells. The plates were incubated for 18 h at 35˚C. Antimicrobial activity was evaluated by measuring the zone of inhibition against the test organism. Ampicillin (10 mg), Streptomycin (10 mg), and Fluconazole (5 mg) were the standard drugs. Dimethyl sulfoxide and ethanol were used as solvent controls.
Results and discussion
The synthesis of the target compounds was carried out as outlined in Schemes 1 and 2.
Compounds 1-4 and 9 are commercially available. The synthesis of compounds 3 and 6 was performed by the reaction of 2 with benzylisothiocyanate (for 3) or benzylisocyanate (for 6). The products 3 and 6 were characterized by their physical, analytical, and spectral data. IR spectra of these compounds showed NH stretching bands between 3380 and 3152 cm −1 . The absorption bands associated with other functional groups appeared in the expected regions. In the 1 H-NMR spectra of the target carbo(thio)amides, the NH protons appeared between 8.67 and 10.48 ppm as D 2 O exchangeable singlets. The intramolecular cyclization of 3 and 6 was performed by basic treatment of these intermediates under reflux conditions. It is well known that 4 type of compounds exist as their thion-mercapto tautomeric forms, and the SH signal due to thiol form is a more downfield singlet than the NH signal derived from thione form. The base catalyzed cyclocondensation of hydrazide (2) with carbondisulfide generated 1,3,4-oxadiazole derivative (9) in good yield under reflux conditions. This compound (9) exhibited spectral data consistent with its structure.
The attempts for aminoalkylations of triazole and oxadiazole derivatives (4, 7, and 9) by Mannich reaction allowed the isolation of the corresponding products (5a-c, 8, and 10a, (14) formed. In the IR spectra of compound 14, the absence of any absorption bands originating from -SH and -NH 2 stretching frequencies clearly indicated fusion between compound 13 and 4-chlorophenacyl bromide. Furthermore, additional signals in the aromatic region were observed due to the 4-chlorophenyl nucleus. 
Antimicrobial activity
All the newly synthesized compounds were tested for their antimicrobial activities and the results obtained are presented in the Table. Among the synthesized compounds, compounds 5a-c displayed no activity against the test microorganisms. The highest activity was observed for compound 11, which contains a 1,3,4-thiadiazole 
Comp. no Microorganisms and inhibition zone (mm) Ec Ea Yp Pa Sa Ef Bc Ms Ca
Sc skeleton and an imine functionality in its structure. When compared to the standard drug ampicillin, compounds 7, 8, and 11 were found to have equal activity against enteric bacteria, Escherichia coli (Ec) and Enterobacter aerogenes (Ea). Very good activity was observed for compound 11 on Yersinia pseudotuberculosis (Yp) and Pseudomonas aeruginosa (Pa), while promising activities were observed for 7 and 8 towards Yp. In fact, compound 7, a 1,2,4-triazol-3-one derivative, and its Mannich base (8) incorporating morpholine moiety exhibited similar activities against Escherichia coli (Ec), Enterobacter aerogenes (Ea), Yersinia pseudotuberculosis (Yp), and a nonpigmented rapidly growing mycobacterium, Mycobacterium smegmatis (Ms), activity.
This result showed that the introduction of morpholine moiety into the structure did not contribute to the activity of compound 7. In fact, for compound 8, this structural modification caused loss of activity towards Staphylococcus aureus (Sa), which is a gram-positive coccus.
Among the Mannich base derivatives (10a,b) of compound 9, 10a displayed good-moderate activity towards the test microorganisms except Ca and Sc, which are yeast-like fungi, while compound 10b showed activity against only Ec, Ea, and Ms. The activity of 10a on Enterococcus faecalis (Ef ) was equal to the activity of ampicillin. When compared to ampicillin, the 4-amino-1,2,4-triazol-3-one compound (12) exhibited equal activity on Ec and Ef, which are gram-positive cocci, and promising activity on Bacillus cereus (Bc), which is a gram-positive spore bacillus, while moderate-slight activities were observed against the other test microorganisms except Ca and Sc.
Compounds 13-15 were found to be active against some of the test microorganisms. The activity of 15 towards Ec and Ea was equal to that of ampicillin. None of the newly synthesized compounds demonstrated activity on yeast-like fungi, Ca and Sc.
